We therefore analyzed the number of CD206+ (an M2 marker) and CD86+ (an M1 marker) macrophages in HCC tissues and revealed that SMAMyD88−/− mice had enhanced M1-like phenotype and reduced M2-like phenotype compared with control mice (Fig. 5A-B). The gene discussed is CD86; the disease is hepatocellular carcinoma.